Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Peripheral Nervous System Diseases × Fumigant 93 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 1 Peripheral Nervous System Diseases 1 Multiple Myeloma 1 Hodgkin Disease 1 Disseminated Intravascular Coagulation 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Age Problem 1

Interventions

Acupuncture Therapy 7 Cryotherapy 6 Paclitaxel 5 Glutamine 5 Exercise 5 Surveys and Questionnaires 2 Sodium Chloride 2 Saline Solution 2 Physical Therapy Modalities 2 Low-Level Light Therapy 2 Lenalidomide 2 Fish Oils 2 Fatty Acids, Omega-3 2 Dexamethasone 2 Bortezomib 2 Acetylcysteine 2 ziconotide 1 sagopilone 1 pembrolizumab 1 nicotinamide-beta-riboside 1 nabilone 1 glutamic acid diethyl ester 1 eribulin 1 enfortumab vedotin 1 allantoicase 1 Yoga 1 XELOX 1 Vitamin D 1 Vitamin B Complex 1 Vitamin B 6 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04732455 2022-07-11

TIPN

Alexandria University

Phase NA Completed

Breast Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡